Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Dijana Djureinovic"'
Autor:
Feria Hikmet, Marc Rassy, Max Backman, Loren Méar, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, Johan Botling, Hans Brunnström, Patrick Micke, Cecilia Lindskog
Publikováno v:
Molecular Oncology, Vol 17, Iss 12, Pp 2603-2617 (2023)
The antigenic repertoire of tumors is critical for successful anti‐cancer immune response and the efficacy of immunotherapy. Cancer–testis antigens (CTAs) are targets of humoral and cellular immune reactions. We aimed to characterize CTA expressi
Externí odkaz:
https://doaj.org/article/d2dba137018343088d9db9aa33cbe23d
Autor:
Dijana Djureinovic, Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi, Lin Zhang, Ana L. Perdigoto, Wei Wei, Gail Anderson, William Damsky, Michael Hurwitz, Barbara Johnson, David Schoenfeld, Amit Mahajan, Frank Hsu, Kathryn Miller-Jensen, Yuval Kluger, Mario Sznol, Susan M. Kaech, Marcus Bosenberg, Lucia B. Jilaveanu, Harriet M. Kluger
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background Stimulating inflammatory tumor associated macrophages can overcome resistance to PD-(L)1 blockade. We previously conducted a phase I trial of cabiralizumab (anti-CSF1R), sotigalimab (CD40-agonist) and nivolumab. Our current purpos
Externí odkaz:
https://doaj.org/article/4fa1a648e79343f59ea5d04accc2e62b
Autor:
Ruth Halaban, Kelly Olino, James Clune, David L Rimm, Harriet M Kluger, Dijana Djureinovic, Wael Ibrahim, Raymond Baumann, Anjela Galan, David G Su, David A. Schoenfeld, Raysa Cabrejo, Sajid A Khan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Desmoplastic melanoma (DM) is a rare melanoma subtype characterized by dense fibrous stroma, a propensity for local recurrence, and a high response rate to programmed cell death protein 1 (PD-1) blockade. Occult sentinel lymph node positiv
Externí odkaz:
https://doaj.org/article/b18e1e486f094e92a9872149f4a497c4
Autor:
Lin Zhang, Harriet Kluger, Lucia Jilaveanu, David A Schoenfeld, Dijana Djureinovic, Jacqueline Mann, John Huck, Aaron M Ring
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ec0db54c3f69417c888449ad5f6c9355
Autor:
Wei Wei, Michael Hurwitz, Sabina Signoretti, Lucia Jilaveanu, Toni K Choueiri, David L Rimm, Adebowale Adeniran, Sandra Martínez, Harriet M Kluger, David A Schoenfeld, Myrto Moutafi, Dijana Djureinovic, Ross D Merkin, David A Braun, Fabio Parisi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background The tumor microenvironment (TME) contributes to cancer progression and treatment response to therapy, including in renal cell carcinoma (RCC). Prior profiling studies, including single-cell transcriptomics, often involve limited sample siz
Externí odkaz:
https://doaj.org/article/9b38124075304f5f862a35be425f0ea0
Autor:
Thuy T. Tran, Jasmine Caulfield, Lin Zhang, David Schoenfeld, Dijana Djureinovic, Veronica L. Chiang, Victor Oria, Sarah A. Weiss, Kelly Olino, Lucia B. Jilaveanu, Harriet M. Kluger
Publikováno v:
JCI Insight, Vol 8, Iss 7 (2023)
Targeting tumor-associated blood vessels to increase immune infiltration may enhance treatment effectiveness, yet limited data exist regarding anti-angiogenesis effects on the tumor microenvironment (TME). We hypothesized that dual targeting of angio
Externí odkaz:
https://doaj.org/article/5120d3e81b654083bf3d1d756be31dfc
Autor:
Dijana Djureinovic, Victor Pontén, Per Landelius, Sahar Al Sayegh, Kai Kappert, Masood Kamali-Moghaddam, Patrick Micke, Elisabeth Ståhle
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients
Externí odkaz:
https://doaj.org/article/2b37e0439d794044857b7c3cffa7fc1e
Publikováno v:
Cancers, Vol 13, Iss 6, p 1302 (2021)
CD40 is expressed on a variety of antigen-presenting cells. Stimulation of CD40 results in inflammation by upregulation of other costimulatory molecules, increased antigen presentation, maturation (licensing) of dendritic cells, and activation of CD8
Externí odkaz:
https://doaj.org/article/57a0bc14ca5547f9926d7032d6d95ac7
Autor:
Harriet M. Kluger, Michael Hurwitz, Mario Sznol, Scott Gettinger, William Damsky, Curtis J. Perry, Susan M. Kaech, Marcus Bosenberg, Ovid Trifan, Amit Mahajan, Wei Wei, Daniel Zelterman, Gail Anderson, Neta Shanwetter Levit, Barbara Johnson, Amanda Ralabate, Lucia Jilaveanu, Lin Zhang, Irina Krykbaeva, Shlomit Jessel, Dijana Djureinovic, Sarah A. Weiss
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a043a703bb58c6fa6b9de5de2a58e8d7
https://doi.org/10.1158/1078-0432.22480427
https://doi.org/10.1158/1078-0432.22480427
Autor:
Harriet M. Kluger, Michael Hurwitz, Mario Sznol, Scott Gettinger, William Damsky, Curtis J. Perry, Susan M. Kaech, Marcus Bosenberg, Ovid Trifan, Amit Mahajan, Wei Wei, Daniel Zelterman, Gail Anderson, Neta Shanwetter Levit, Barbara Johnson, Amanda Ralabate, Lucia Jilaveanu, Lin Zhang, Irina Krykbaeva, Shlomit Jessel, Dijana Djureinovic, Sarah A. Weiss
Association between pre-treatment CD4+ T-cell density from available baseline tumor tissue (n=14) and the duration of time on treatment in days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8b5eba52845695c761885ea1138d92
https://doi.org/10.1158/1078-0432.22480430.v1
https://doi.org/10.1158/1078-0432.22480430.v1